Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251913 | SCV000303941 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Cardiovascular Research Group, |
RCV000256231 | SCV000322822 | benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Illumina Laboratory Services, |
RCV000256231 | SCV000427196 | likely benign | Hypercholesterolemia, familial, 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000251913 | SCV000568078 | benign | not specified | 2016-10-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory of Genetics and Molecular Cardiology, |
RCV000256231 | SCV000588409 | benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000845489 | SCV000987587 | benign | not provided | criteria provided, single submitter | clinical testing | ||
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000251913 | SCV001469338 | benign | not specified | 2019-11-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001837802 | SCV001728420 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Cohesion Phenomics | RCV002287892 | SCV002578241 | benign | Familial hypercholesterolemia | 2022-09-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002450767 | SCV002615097 | benign | Cardiovascular phenotype | 2015-12-10 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
GENin |
RCV002287892 | SCV005074086 | benign | Familial hypercholesterolemia | 2022-06-23 | criteria provided, single submitter | clinical testing | |
OMIM | RCV003389246 | SCV000039776 | benign | APOB POLYMORPHISM IN SIGNAL PEPTIDE | 1990-03-01 | no assertion criteria provided | literature only | |
Department of Pathology and Laboratory Medicine, |
RCV000845489 | SCV001550340 | uncertain significance | not provided | no assertion criteria provided | clinical testing | multiple AR variants in same gene - keep for nowAllele frequency is common in at least one population database (frequency: 26.862% in gnomAD_Genomes) based on the frequency threshold of 1.253% for this gene.Variant was observed in a homozygous state in population databases more than expected for disease.In-frame deletion in a repetitive region is less likely to be pathogenic. | |
Clinical Genetics, |
RCV000251913 | SCV001925443 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000251913 | SCV001962778 | benign | not specified | no assertion criteria provided | clinical testing |